Brief: Biophytis Enrolls First Patient in Brazil in COVA

Biophytis SA

26/10/2020 06:03

Oct 26 (Reuters) - Biophytis SA  ALBPS.PA :
    * ENROLLS FIRST PATIENT IN BRAZIL IN COVA, A MULTINATIONAL
PHASE
2/3 CLINICAL TRIAL WITH SARCONEOS (BIO101) FOR TREATMENT OF
PATIENTS WITH COVID-19 RELATED RESPIRATORY FAILURE
    * ENROLLS FIRST PATIENT IN BRAZIL IN COVA, A MULTINATIONAL
PHASE
2/3 CLINICAL TRIAL WITH SARCONEOS (BIO101) FOR TREATMENT OF
PATIENTS WITH COVID-19 RELATED RESPIRATORY FAILURE
    * TEN CENTERS NOW OPEN FOR PATIENT RECRUITMENT IN EUROPE AND
THE
AMERICAS
    * SECOND PART OF STUDY WILL INVESTIGATE EFFICACY OF
SARCONEOS
(BIO101) ON RESPIRATORY FUNCTION OF ADDITIONAL 260 COVID-19
PATIENTS

Source text for Eikon:  ID:nNDL99njth 
Further company coverage:  ALBPS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))